October 10, 2018
A Swedish investment firm Wednesday accused Teva Pharmaceuticals in Connecticut federal court of lying to shareholders about an alleged scheme to pump up its share prices through a series of unsustainable price hikes that ultimately resulted in a spate of antitrust suits and the collapse of its market value.